(S)-N-methyl-1-(7-methyl-4,7-dihydro-5H-thieno[2,3-c]pyran-7-yl)methanamine

ID: ALA5094291

PubChem CID: 166631215

Max Phase: Preclinical

Molecular Formula: C10H15NOS

Molecular Weight: 197.30

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC[C@]1(C)OCCc2ccsc21

Standard InChI:  InChI=1S/C10H15NOS/c1-10(7-11-2)9-8(3-5-12-10)4-6-13-9/h4,6,11H,3,5,7H2,1-2H3/t10-/m0/s1

Standard InChI Key:  KJOMHRUJAVDLSX-JTQLQIEISA-N

Molfile:  

 
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   40.2735  -14.2802    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.2735  -15.0974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9788  -15.5019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9788  -13.8675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6841  -14.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6885  -15.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4637  -15.3411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.9384  -14.6802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4565  -14.0246    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   40.9788  -13.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2711  -12.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.5634  -13.0503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6809  -13.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 11 12  1  0
  4 13  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5094291

    ---

Associated Targets(Human)

TAAR1 Tclin Trace amine-associated receptor 1 (1397 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 197.30Molecular Weight (Monoisotopic): 197.0874AlogP: 1.76#Rotatable Bonds: 2
Polar Surface Area: 21.26Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.40CX LogP: 1.78CX LogD: -0.20
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.78Np Likeness Score: 0.00

References

1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L..  (2022)  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.,  13  (1.0): [PMID:35047111] [10.1021/acsmedchemlett.1c00527]

Source